Dupixent Keeps Sanofi At Forefront Of European Pharma Growth

Hints At Raised Forecast For Blockbuster

 
• By Andrew McConaghie
  
Sanofi_Berlin
A forecast 14% rise in earnings per share in 2021 will put Sanofi among the top European big pharma performers. • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip